Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer

BACKGROUND: Along with the development of new cancer therapeutics, more effective tools for the estimation of response to therapy and prediction of disease progression are required for the better management of inoperable cancer patients. METHODS: We studied 134 newly diagnosed and primarily untreate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sachin, Guleria, Randeep, Singh, Vikas, Bharti, Alok C, Mohan, Anant, Das, Bhudev C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796678/
https://www.ncbi.nlm.nih.gov/pubmed/19958548
http://dx.doi.org/10.1186/1471-2407-9-421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796678/
https://www.ncbi.nlm.nih.gov/pubmed/19958548
http://dx.doi.org/10.1186/1471-2407-9-421

Ejemplares similares